跳至主要内容
临床试验/NCT07689760
NCT07689760Enrolling By Invitation不适用

Explainable AI for Predicting Hospital Admissions in Heart Failure: ExplAIn-HF

Medisch Spectrum Twente1 个研究点 分布在 1 个国家目标入组 95 人开始时间: 2026年7月13日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
95
试验地点
1
主要终点
Heart failure (HF) event

研究概览

简要总结

The goal of this observational study is to develop and validate an XAI based model that predicts HF events and identifies modifiable con-tributing factors, and to evaluate the added value of integrating high frequency smartwatch data compared to usual care in patients with heart failure. The main objectives of the study are:

  1. To develop and validate an XAI based model that predicts HF events and identifies modifiable contributing factors, and to evaluate the added value of integrating high frequency smartwatch data compared to usual care. In the Netherlands usual care includes remote monitoring of heartrate, blood pressure, weight and symptoms.
  2. To include insights of the smartwatch into activity patterns, impact on quality of life (KCCQ-12), and patient satisfaction with net promoter score (NPS).

Participants will wear a smartwatch for six months and perform an I-lead ecg with the smartwatch weekly.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult HF patients
  • NYHA class II, or NYHA III
  • Rehospitalization for HF
  • Usual care with active participation in the telemonitoring program "Zorg Bij Jou" (ZBJ)
  • Possession of an iPhone 11 or newer and compatible with the study apps

排除标准

  • Lack of digital literacy or inability to use the device
  • Not capable to sign consent
  • Referral to hospice

研究组 & 干预措施

Heart failure patients

结局指标

主要结局

Heart failure (HF) event

时间窗: From enrollment to the end of follow-up at 6 months

HF event is defined as: * Increase in diuretic treatment * Increase in NYHA class * Hospitalization caused by HF * Death caused by HF

次要结局

  • Activity patterns(From enrollment to the end of follow-up at 6 months)
  • Quality of life (QoL)(Measured at baseline and at the end of follow-up at 6 months)
  • Net promotor score (NPS)(At the end of follow-up at 6 months)
  • Quality of life (QoL)(Measured at baseline and at the end of follow-up at 6 months. The Kansas City Cardiomyopathy Questionnaire is scored on a scale of 0 to 100; higher scores indicate better health.)
  • Net promotor score(At the end of follow-up at 6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验